UniProt ID | CN37_HUMAN | |
---|---|---|
UniProt AC | P09543 | |
Protein Name | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | |
Gene Name | CNP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 421 | |
Subcellular Localization |
Membrane Lipid-anchor. Melanosome. Firmly bound to membrane structures of brain white matter. Identified by mass spectrometry in melanosome fractions from stage I to stage IV. |
|
Protein Description | May participate in RNA metabolism in the myelinating cell, CNP is the third most abundant protein in central nervous system myelin.. | |
Protein Sequence | MNRGFSRKSHTFLPKIFFRKMSSSGAKDKPELQFPFLQDEDTVATLLECKTLFILRGLPGSGKSTLARVIVDKYRDGTKMVSADAYKITPGARGAFSEEYKRLDEDLAAYCRRRDIRILVLDDTNHERERLEQLFEMADQYQYQVVLVEPKTAWRLDCAQLKEKNQWQLSADDLKKLKPGLEKDFLPLYFGWFLTKKSSETLRKAGQVFLEELGNHKAFKKELRQFVPGDEPREKMDLVTYFGKRPPGVLHCTTKFCDYGKAPGAEEYAQQDVLKKSYSKAFTLTISALFVTPKTTGARVELSEQQLQLWPSDVDKLSPTDNLPRGSRAHITLGCAADVEAVQTGLDLLEILRQEKGGSRGEEVGELSRGKLYSLGNGRWMLTLAKNMEVRAIFTGYYGKGKPVPTQGSRKGGALQSCTII | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MNRGFSRKSHTFL --CCCCCCCCCCCHH | 41.44 | 23403867 | |
8 | Ubiquitination | MNRGFSRKSHTFLPK CCCCCCCCCCCHHHH | 45.45 | - | |
9 | Phosphorylation | NRGFSRKSHTFLPKI CCCCCCCCCCHHHHH | 27.01 | 22617229 | |
11 | Phosphorylation | GFSRKSHTFLPKIFF CCCCCCCCHHHHHHH | 33.68 | 23403867 | |
15 | Ubiquitination | KSHTFLPKIFFRKMS CCCCHHHHHHHHHCC | 55.05 | 21890473 | |
15 (in isoform 1) | Ubiquitination | - | 55.05 | 21890473 | |
22 | Phosphorylation | KIFFRKMSSSGAKDK HHHHHHCCCCCCCCC | 25.12 | 26657352 | |
23 | Phosphorylation | IFFRKMSSSGAKDKP HHHHHCCCCCCCCCC | 29.32 | 28464451 | |
24 | Phosphorylation | FFRKMSSSGAKDKPE HHHHCCCCCCCCCCC | 35.15 | 28464451 | |
27 | Methylation | KMSSSGAKDKPELQF HCCCCCCCCCCCCCC | 70.57 | 12692561 | |
29 | Methylation | SSSGAKDKPELQFPF CCCCCCCCCCCCCCC | 39.42 | 12692561 | |
29 | Ubiquitination | SSSGAKDKPELQFPF CCCCCCCCCCCCCCC | 39.42 | - | |
42 | Phosphorylation | PFLQDEDTVATLLEC CCCCCHHHHHHHHHC | 15.25 | 26552605 | |
49 | Glutathionylation | TVATLLECKTLFILR HHHHHHHCCEEEHHC | 4.04 | 22555962 | |
51 | Phosphorylation | ATLLECKTLFILRGL HHHHHCCEEEHHCCC | 38.26 | 23882029 | |
53 (in isoform 2) | Ubiquitination | - | 6.30 | 21890473 | |
63 | Ubiquitination | RGLPGSGKSTLARVI CCCCCCCCHHHHHHH | 41.80 | - | |
64 | Phosphorylation | GLPGSGKSTLARVIV CCCCCCCHHHHHHHH | 31.98 | 24076635 | |
65 | Phosphorylation | LPGSGKSTLARVIVD CCCCCCHHHHHHHHH | 28.11 | 25332170 | |
67 (in isoform 2) | Ubiquitination | - | 12.09 | 21890473 | |
73 | Ubiquitination | LARVIVDKYRDGTKM HHHHHHHCCCCCCEE | 31.15 | 21890473 | |
73 (in isoform 1) | Ubiquitination | - | 31.15 | 21890473 | |
79 | Acetylation | DKYRDGTKMVSADAY HCCCCCCEEEECEEE | 42.72 | 25953088 | |
79 | Malonylation | DKYRDGTKMVSADAY HCCCCCCEEEECEEE | 42.72 | 26320211 | |
79 | Ubiquitination | DKYRDGTKMVSADAY HCCCCCCEEEECEEE | 42.72 | - | |
81 (in isoform 2) | Ubiquitination | - | 4.56 | 21890473 | |
82 | Phosphorylation | RDGTKMVSADAYKIT CCCCEEEECEEEECC | 19.55 | 28258704 | |
86 | Phosphorylation | KMVSADAYKITPGAR EEEECEEEECCCCCC | 11.94 | 21253578 | |
87 | Ubiquitination | MVSADAYKITPGARG EEECEEEECCCCCCC | 41.65 | 21890473 | |
87 (in isoform 1) | Ubiquitination | - | 41.65 | 21890473 | |
89 | Phosphorylation | SADAYKITPGARGAF ECEEEECCCCCCCCC | 16.12 | 20049867 | |
97 | Phosphorylation | PGARGAFSEEYKRLD CCCCCCCCHHHHHCC | 29.05 | 25332170 | |
100 | Phosphorylation | RGAFSEEYKRLDEDL CCCCCHHHHHCCHHH | 9.43 | 21253578 | |
101 | Ubiquitination | GAFSEEYKRLDEDLA CCCCHHHHHCCHHHH | 50.17 | 21890473 | |
101 (in isoform 1) | Ubiquitination | - | 50.17 | 21890473 | |
110 | Phosphorylation | LDEDLAAYCRRRDIR CCHHHHHHHHHCCCE | 4.85 | 20007894 | |
124 | Phosphorylation | RILVLDDTNHERERL EEEEECCCCHHHHHH | 37.83 | 25332170 | |
141 | Phosphorylation | LFEMADQYQYQVVLV HHHHHHHCCEEEEEE | 15.10 | - | |
155 (in isoform 2) | Ubiquitination | - | 20.41 | 21890473 | |
162 | Acetylation | RLDCAQLKEKNQWQL EECHHHHHHHCCEEC | 55.34 | 25953088 | |
162 | Malonylation | RLDCAQLKEKNQWQL EECHHHHHHHCCEEC | 55.34 | 26320211 | |
162 | Ubiquitination | RLDCAQLKEKNQWQL EECHHHHHHHCCEEC | 55.34 | - | |
164 | Ubiquitination | DCAQLKEKNQWQLSA CHHHHHHHCCEECCH | 53.50 | - | |
170 | Phosphorylation | EKNQWQLSADDLKKL HHCCEECCHHHHHHH | 17.98 | 19664994 | |
175 | 2-Hydroxyisobutyrylation | QLSADDLKKLKPGLE ECCHHHHHHHCCCCC | 64.15 | - | |
175 | Acetylation | QLSADDLKKLKPGLE ECCHHHHHHHCCCCC | 64.15 | 23236377 | |
175 | Malonylation | QLSADDLKKLKPGLE ECCHHHHHHHCCCCC | 64.15 | 26320211 | |
175 | Succinylation | QLSADDLKKLKPGLE ECCHHHHHHHCCCCC | 64.15 | 23954790 | |
175 | Ubiquitination | QLSADDLKKLKPGLE ECCHHHHHHHCCCCC | 64.15 | 21890473 | |
175 (in isoform 1) | Ubiquitination | - | 64.15 | 21890473 | |
176 | Ubiquitination | LSADDLKKLKPGLEK CCHHHHHHHCCCCCC | 69.87 | - | |
178 | Malonylation | ADDLKKLKPGLEKDF HHHHHHHCCCCCCCC | 46.01 | 26320211 | |
178 | Succinylation | ADDLKKLKPGLEKDF HHHHHHHCCCCCCCC | 46.01 | 27452117 | |
197 | Ubiquitination | FGWFLTKKSSETLRK HHHHHCCCCHHHHHH | 54.71 | - | |
197 (in isoform 2) | Ubiquitination | - | 54.71 | 21890473 | |
204 | Malonylation | KSSETLRKAGQVFLE CCHHHHHHHHHHHHH | 61.04 | 26320211 | |
204 | Ubiquitination | KSSETLRKAGQVFLE CCHHHHHHHHHHHHH | 61.04 | - | |
217 | Ubiquitination | LEELGNHKAFKKELR HHHHCCCHHHHHHHH | 60.56 | 21890473 | |
217 (in isoform 1) | Ubiquitination | - | 60.56 | 21890473 | |
220 | Ubiquitination | LGNHKAFKKELRQFV HCCCHHHHHHHHHHC | 50.64 | - | |
221 | Ubiquitination | GNHKAFKKELRQFVP CCCHHHHHHHHHHCC | 56.37 | - | |
235 | 2-Hydroxyisobutyrylation | PGDEPREKMDLVTYF CCCCCHHHCCEEHHC | 38.71 | - | |
235 | Ubiquitination | PGDEPREKMDLVTYF CCCCCHHHCCEEHHC | 38.71 | - | |
240 | Phosphorylation | REKMDLVTYFGKRPP HHHCCEEHHCCCCCC | 22.04 | 21406692 | |
241 | Phosphorylation | EKMDLVTYFGKRPPG HHCCEEHHCCCCCCC | 11.67 | 21406692 | |
241 (in isoform 2) | Ubiquitination | - | 11.67 | 21890473 | |
244 | Ubiquitination | DLVTYFGKRPPGVLH CEEHHCCCCCCCEEE | 52.40 | - | |
255 | Acetylation | GVLHCTTKFCDYGKA CEEEEECCCCCCCCC | 26.33 | 26051181 | |
255 | Ubiquitination | GVLHCTTKFCDYGKA CEEEEECCCCCCCCC | 26.33 | - | |
255 (in isoform 2) | Ubiquitination | - | 26.33 | 21890473 | |
261 | Ubiquitination | TKFCDYGKAPGAEEY CCCCCCCCCCCHHHH | 45.22 | 22053931 | |
275 | Ubiquitination | YAQQDVLKKSYSKAF HHHHHHHHHHHHHCE | 39.25 | 21890473 | |
275 (in isoform 1) | Ubiquitination | - | 39.25 | 21890473 | |
276 | Ubiquitination | AQQDVLKKSYSKAFT HHHHHHHHHHHHCEE | 50.93 | - | |
277 | Phosphorylation | QQDVLKKSYSKAFTL HHHHHHHHHHHCEEE | 32.81 | 21406692 | |
278 | Phosphorylation | QDVLKKSYSKAFTLT HHHHHHHHHHCEEEE | 24.07 | 21406692 | |
279 | Phosphorylation | DVLKKSYSKAFTLTI HHHHHHHHHCEEEEE | 25.30 | 21406692 | |
283 | Phosphorylation | KSYSKAFTLTISALF HHHHHCEEEEEEEEE | 28.05 | 21406692 | |
285 | Phosphorylation | YSKAFTLTISALFVT HHHCEEEEEEEEEEC | 15.16 | 21406692 | |
287 | Phosphorylation | KAFTLTISALFVTPK HCEEEEEEEEEECCC | 17.43 | 21406692 | |
292 | Phosphorylation | TISALFVTPKTTGAR EEEEEEECCCCCCCE | 16.25 | 21406692 | |
295 | Phosphorylation | ALFVTPKTTGARVEL EEEECCCCCCCEEEE | 31.50 | 21406692 | |
296 | Phosphorylation | LFVTPKTTGARVELS EEECCCCCCCEEEEC | 34.66 | 21406692 | |
296 (in isoform 2) | Ubiquitination | - | 34.66 | 21890473 | |
303 | Phosphorylation | TGARVELSEQQLQLW CCCEEEECHHHHHHC | 21.61 | 24076635 | |
312 | Phosphorylation | QQLQLWPSDVDKLSP HHHHHCCCCCHHCCC | 38.39 | 18510355 | |
316 | Ubiquitination | LWPSDVDKLSPTDNL HCCCCCHHCCCCCCC | 51.19 | 22053931 | |
316 (in isoform 1) | Ubiquitination | - | 51.19 | 21890473 | |
318 | Phosphorylation | PSDVDKLSPTDNLPR CCCCHHCCCCCCCCC | 31.34 | 30266825 | |
320 | Phosphorylation | DVDKLSPTDNLPRGS CCHHCCCCCCCCCCC | 33.86 | 30266825 | |
327 | Phosphorylation | TDNLPRGSRAHITLG CCCCCCCCCEEEEEC | 27.81 | 24076635 | |
356 | Ubiquitination | LEILRQEKGGSRGEE HHHHHHHCCCCCCCC | 61.30 | - | |
359 | Phosphorylation | LRQEKGGSRGEEVGE HHHHCCCCCCCCCCC | 45.86 | - | |
366 (in isoform 2) | Ubiquitination | - | 49.07 | - | |
368 | Phosphorylation | GEEVGELSRGKLYSL CCCCCCCCCCEEEEE | 34.38 | 25332170 | |
371 | Ubiquitination | VGELSRGKLYSLGNG CCCCCCCEEEEECCC | 43.04 | - | |
373 | Phosphorylation | ELSRGKLYSLGNGRW CCCCCEEEEECCCCE | 12.82 | 22817900 | |
383 | Phosphorylation | GNGRWMLTLAKNMEV CCCCEEEEEECCCEE | 14.47 | 19664995 | |
406 | Phosphorylation | GKGKPVPTQGSRKGG CCCCCCCCCCCCCCC | 45.88 | 28857561 | |
409 | Phosphorylation | KPVPTQGSRKGGALQ CCCCCCCCCCCCCCC | 22.47 | 28857561 | |
418 | Farnesylation | KGGALQSCTII---- CCCCCCCCEEC---- | 1.72 | - | |
418 | Methylation | KGGALQSCTII---- CCCCCCCCEEC---- | 1.72 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
9 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
9 | S | Phosphorylation | Kinase | PKC_GROUP | - | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CN37_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CN37_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SIR3_HUMAN | SIRT3 | physical | 26186194 | |
SIR3_HUMAN | SIRT3 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-170, AND MASSSPECTROMETRY. |